Clinical Perinatal Software Market Outlook:
Clinical Perinatal Software Market size was valued at USD 308.04 million in 2025 and is set to exceed USD 756.45 million by 2035, registering over 9.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of clinical perinatal software is evaluated at USD 334.1 million.
The increasing prevalence of complications during and after pregnancy and growing awareness of maternal health issues are driving a high need for advanced healthcare solutions including perinatal software technologies. Gestational diabetes, anxiety, perinatal depression, and hypertension are the major issues that are observed during pregnancy among women. According to the World Health Organization (WHO), around 10% of pregnant women and 13% of women who have just given birth experience mental issues such as depression, globally. The depression rate is much higher in women living in developing economies, accounting for 15.6% during pregnancy and 19.8% after birth.
Obesity and advanced maternal age are some of the prime factors contributing to the increasing incidence of gestational diabetes. Also, hypertension and preeclampsia that arise during pregnancy can lead to serious complications. For instance, the National Institutes of Health estimates that the prevalence of preeclampsia ranges between 2% to 20%, globally. These pregnancy-related issues result in high demand for advanced clinical perinatal software solutions that offer tools such as glucose tracking, reminders for dietary management, and regular communications between patients and healthcare providers.
